Boston Scientific Corp.

Boston Scientific has announced its largest transaction this year: an acquisition of a Bedford prostate health firm for up to $600 million.

A Texas man on the National Do Not Call Registry is alleging Marlborough medical device giant Boston Scientific made unsolicited robocalls to him to market a spinal cord stimulation device.

Boston Scientific will soon submit the final technical module to the U.S. Food and Drug Administration for a heart valve product.

Boston Scientific is showing no signs of slowing its aggressive acquisition strategy as the medical device giant is set to acquire a privately held obstructive disease firm for up to $160 million.

Boston Scientific has announced its seventh acquisition of 2018, signing an agreement to take over California-based Claret Medical for up to $270 million.

Shares of Marlborough medical device giant Boston Scientific rose as high as 17 percent Monday after reports the company could be sold to rival Stryker Corp., based in Michigan.

Medical device maker Boston Scientific is responding after a “60 Minutes” segment that aired Sunday highlighted claims that the company's transvaginal mesh products are ineffective and harmful.

Marlborough medical device maker Boston Scientific is reporting a fourth-quarter loss of $615 million, primarily due to an $861-million tax charge to bring foreign earnings to the U.S.

Marlborough medical device maker Boston Scientific announced Wednesday an agreement with Santa Rosa-based Millipede, Inc. to potentially acquire the California firm for $540 million.

The price of Marlborough medical device maker Boston Scientific's stock has fallen nearly 9 percent since the close of market trading on Monday, fueled by an announced delay to its Lotus Edge Aortic Valve System in the U.S. and Europe.